Rapid reversal of psychotic depression using mifepristone

Journal of Clinical Psychopharmacology

Volumn 21, Issue 5, 2001, Pages 516-521

  Belanoff, Joseph K ^a   Flores, Benjamin H ^a   Kalezhan, Michelle ^a   Sund, Brenda ^a   Schatzberg, Alan F ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; GLUCOCORTICOID RECEPTOR ANTAGONIST; MIFEPRISTONE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; FEMALE; HAMILTON SCALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SHORT COURSE THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; BRIEF PSYCHIATRIC RATING SCALE; CROSS-OVER STUDIES; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HORMONE ANTAGONISTS; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; MIFEPRISTONE; PSYCHOTIC DISORDERS; TIME FACTORS;

EID: 0034800312     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200110000-00009     Document Type: Article

References (40)

1. Psychotic (delusional) major depression: Should it be included as a distinct syndrome in DSM-IV?
2. The clinical and neuroendocrine features of psychotic depression
3. Delusional depression: Phenomenology and response to treatment. A prospective study
4. Psychotic depression: A separate entity?
5. Delusional depression: A distinct clinical entity?
6. Delusional unipolar depression
7. Delusional and nondelusional unipolar depression: Further evidence for distinct subtypes
8. DST studies in psychotic depression: A metaanalysis
9. Delusional depression: Phenomenology, neuroendocrine function, and tricyclic antidepressant response
10. Subtypes of depression: Family study perspective
11. Delusional depression: A one year follow-up
12. Delusional depressions: Natural history and response to treatment
13. Delusional depression: A review of the literature and current perspectives
14. The pharmacological treatment of delusional depression
15. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants
16. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression
17. DST studies in psychotic depression: A metaanalysis
18. Urinary free cortisol in psychotic depression
19. The dexamethasone suppression test as a discriminator among subtypes of psychotic patients
20. The dexamethasone suppression test in psychotic disorders
21. Depression, delusions, and drug response
22. Depression treated with imipramine and ECT: The DeCarolis study reconsidered
23. The treatment of psychotic major depressive disorder with drugs and electroconvulsive therapy
24. Potent anti-glucocorticoid activity of mifepristone on ACTH secretion in vitro and in vivo in the rat
25. Studies on the glucocorticoid receptor blocking action of RU 38486 in cultured ACTH-secreting human pituitary tumor cells and normal rat pituitary cells
26. Administration of RU 486 for 8 days in normal volunteers: Antiglucocorticoid effect with no evidence of peripheral cortisol deprivation
27. Rapid reversal of acute psychosis in the Cushing syndrome with the cortisolreceptor antagonist mifepristone (RU 486)
28. Successful treatment of cushing syndrome with the glucocorticoid antagonist mifepristone
29. Uses of RU 486 as an antiglucocorticoid
30. The endocrine effects of long-term treatment with mifepristone
31. Long-term treatment with the oral antiprogestational agent mifepristone
32. Effect of chronic treatment with the glucocorticoid antagonist mifepristone in men: Toxicity, immunological, and hormonal aspects
33. Clinical applications of mifepristone, a prototype glucocorticoid and progestin antagonist
34. Possible use of glucocorticoid antagonists in the treatment of major depression: Preliminary results using mifepristone
35. A rating scale for depression
36. Brain corticosteroid receptor balance and homeostatic control
37. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
38. The endocrine effects of long-term treatment with mifepristone (RU 486)
39. Glucocorticoid and mineralo-corticoid receptor mRNA expression in squirrel monkey brain
40. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness